Follow
M. Katharine Holloway
M. Katharine Holloway
Gfree Bio LLC
Verified email at gfreebio.com - Homepage
Title
Cited by
Cited by
Year
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor
JP Vacca, BD Dorsey, WA Schleif, RB Levin, SL McDaniel, PL Darke, ...
Proc. Nat. Acad. Sci. U.S.A. 91, 4096, 1994
6971994
L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor.
BD Dorsey, RB Levin, SL McDaniel, JP Vacca, JP Guare, PL Darke, ...
J. Med. Chem. 37, 3443, 1994
5461994
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase
DJ Hazuda, NJ Anthony, RP Gomez, SM Jolly, JS Wai, L Zhuang, ...
Proceedings of the National Academy of Sciences 101 (31), 11233-11238, 2004
4182004
Structure-based design of potent and selective cell-permeable inhibitors of human β-secretase (BACE-1)
SJ Stachel, CA Coburn, TG Steele, KG Jones, EF Loutzenhiser, ...
Journal of medicinal chemistry 47 (26), 6447-6450, 2004
3812004
4-Aryl-2, 4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells
JS Wai, MS Egbertson, LS Payne, TE Fisher, MW Embrey, LO Tran, ...
Journal of medicinal chemistry 43 (26), 4923-4926, 2000
3222000
A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site
MK Holloway, JM Wai, TA Halgren, PMD Fitzgerald, JP Vacca, BD Dorsey, ...
Journal of medicinal chemistry 38 (2), 305-317, 1995
3091995
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted design.
WJ Thompson, PM Fitzgerald, MK Holloway, EA Emini, PL Darke, ...
Journal of medicinal chemistry 35 (10), 1685-1701, 1992
2181992
Discovery of MK-5172, a macrocyclic hepatitis C virus NS3/4a protease inhibitor
S Harper, JA McCauley, MT Rudd, M Ferrara, M DiFilippo, B Crescenzi, ...
ACS medicinal chemistry letters 3 (4), 332-336, 2012
1992012
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor
JA McCauley, CJ McIntyre, MT Rudd, KT Nguyen, JJ Romano, ...
Journal of medicinal chemistry 53 (6), 2443-2463, 2010
1992010
X-ray crystal structure of the HIV protease complex with L-700,417, an inhibitor with pseudo C2 symmetry
R Bone, JP Vacca, PS Anderson, MK Holloway
Journal of the American Chemical Society 113 (24), 9382-9384, 1991
1971991
Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease
NJ Liverton, MK Holloway, JA McCauley, MT Rudd, JW Butcher, ...
Journal of the American Chemical Society 130 (14), 4607-4609, 2008
1672008
Thermodynamics of ligand binding and efficiency
CH Reynolds, MK Holloway
ACS medicinal chemistry letters 2 (6), 433-437, 2011
1632011
Identification of a small molecule nonpeptide active site β-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases
CA Coburn, SJ Stachel, YM Li, DM Rush, TG Steele, E Chen-Dodson, ...
Journal of medicinal chemistry 47 (25), 6117-6119, 2004
1592004
HIV protease inhibitors useful for the treatment of AIDS
JP Vacca, BD Dorsey, JP Guare, MK Holloway, RW Hungate, RB Levin
US Patent 5,527,799, 1996
1591996
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease
NJ Liverton, SS Carroll, J DiMuzio, C Fandozzi, DJ Graham, D Hazuda, ...
Antimicrobial Agents and Chemotherapy 54 (1), 305-311, 2010
1542010
First demonstration of cerebrospinal fluid and plasma Aβ lowering with oral administration of a β-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates
S Sankaranarayanan, MA Holahan, D Colussi, MC Crouthamel, ...
Journal of Pharmacology and Experimental Therapeutics 328 (1), 131-140, 2009
1292009
Drug-like density: a method of quantifying the “bindability” of a protein target based on a very large set of pockets and drug-like ligands from the Protein Data Bank
RP Sheridan, VN Maiorov, MK Holloway, WD Cornell, YD Gao
Journal of chemical information and modeling 50 (11), 2029-2040, 2010
1172010
Macrocyclic inhibitors of β-secretase: functional activity in an animal model
SJ Stachel, CA Coburn, S Sankaranarayanan, EA Price, BL Pietrak, ...
Journal of medicinal chemistry 49 (21), 6147-6150, 2006
1152006
Conformationally biased P3 amide replacements of β-secretase inhibitors
SJ Stachel, CA Coburn, TG Steele, MC Crouthamel, BL Pietrak, MT Lai, ...
Bioorganic & medicinal chemistry letters 16 (3), 641-644, 2006
1082006
Design and Synthesis of Peptidomimetic Inhibitors of HIV-1 Protease and Renin. Evidence for Improved Transport.
AB Smith, R Hirschmann, A Pasternak, R Akaishi, MC Guzman, DR Jones, ...
Journal of Medicinal Chemistry 37, 215-218, 1994
1081994
The system can't perform the operation now. Try again later.
Articles 1–20